Updates in Breast Cancer from San Antonio


 

SABCS 2019 Highlights on ER+ mBC: Palbociclib + ET Is Better Tolerated Than Capecitabine, but not More Effective + Menopausal Estrogen Replacement Reduced BC Risk and Mortality

0 views
February 10, 2020
Comments 0
Login to view comments. Click here to Login